These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2917423

  • 1. Serum terminal complement component levels in hypocomplementemic glomerulonephritides.
    Clardy CW, Forristal J, Strife CF, West CD.
    Clin Immunol Immunopathol; 1989 Mar; 50(3):307-20. PubMed ID: 2917423
    [Abstract] [Full Text] [Related]

  • 2. Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.
    Varade WS, Forristal J, West CD.
    Am J Kidney Dis; 1990 Sep; 16(3):196-206. PubMed ID: 2205097
    [Abstract] [Full Text] [Related]

  • 3. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
    Clardy CW, Forristal J, Strife CF, West CD.
    Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effect of free sialic acid on complement activation and its significance in hypocomplementemic glomerulonephritis.
    Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H.
    J Clin Lab Anal; 1999 Mar; 13(4):173-9. PubMed ID: 10414597
    [Abstract] [Full Text] [Related]

  • 5. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
    Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G, Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy, Nastasi.
    J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
    [Abstract] [Full Text] [Related]

  • 6. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
    Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, Rubis N, Peraro F, Gaspari F, Pasini A, Rigotti A, Lerchner RM, Santoro D, Pisani A, Pasi A, Remuzzi G, EAGLE Study Group.
    Am J Kidney Dis; 2019 Aug; 74(2):224-238. PubMed ID: 30929851
    [Abstract] [Full Text] [Related]

  • 7. Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis.
    Wyatt RJ, McAdams AJ, Forristal J, Snyder J, West CD.
    Kidney Int; 1979 Oct; 16(4):505-12. PubMed ID: 398417
    [Abstract] [Full Text] [Related]

  • 8. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
    [Abstract] [Full Text] [Related]

  • 9. A hemolytic method for the measurement of nephritic factor.
    West CD.
    J Immunol Methods; 2008 Jun 01; 335(1-2):1-7. PubMed ID: 18410942
    [Abstract] [Full Text] [Related]

  • 10. Discordant renal histopathologic findings and complement profiles in membranoproliferative glomerulonephritis type III.
    Meyers KE, Strife CF, Witzleben C, Kaplan BS.
    Am J Kidney Dis; 1996 Dec 01; 28(6):804-10. PubMed ID: 8957031
    [Abstract] [Full Text] [Related]

  • 11. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov 01; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 12. Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.
    Strife CF, Prada AL, Clardy CW, Jackson E, Forristal J.
    J Pediatr; 1990 May 01; 116(5):S98-102. PubMed ID: 2329415
    [Abstract] [Full Text] [Related]

  • 13. Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement Activation.
    Carrara C, Podestà MA, Abbate M, Rizzo P, Piras R, Alberti M, Daina E, Ruggenenti P, Remuzzi G, on behalf of the EAGLE Study Group.
    Nephron; 2020 May 01; 144(4):195-203. PubMed ID: 32050203
    [Abstract] [Full Text] [Related]

  • 14. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH, Lambert PH, Miescher PA.
    J Clin Invest; 1975 Jul 01; 56(1):165-76. PubMed ID: 1141431
    [Abstract] [Full Text] [Related]

  • 15. [C3 production by peripheral blood monocytes in patients with membranoproliferative glomerulonephritis and poststreptococcal glomerulonephritis].
    Yan K.
    Nihon Jinzo Gakkai Shi; 1993 Feb 01; 35(2):151-60. PubMed ID: 8315878
    [Abstract] [Full Text] [Related]

  • 16. Classical complement pathway activation in membranoproliferative glomerulonephritis.
    Ooi YM, Vallota EH, West CD.
    Kidney Int; 1976 Jan 01; 9(1):46-53. PubMed ID: 781380
    [Abstract] [Full Text] [Related]

  • 17. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation.
    Jackson EC, McAdams AJ, Strife CF, Forristal J, Welch TR, West CD.
    Am J Kidney Dis; 1987 Feb 01; 9(2):115-20. PubMed ID: 3826060
    [Abstract] [Full Text] [Related]

  • 18. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1998 Jul 01; 32(1):56-63. PubMed ID: 9669425
    [Abstract] [Full Text] [Related]

  • 19. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr 01; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 20. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion.
    Sethi S, Nester CM, Smith RJ.
    Kidney Int; 2012 Mar 01; 81(5):434-41. PubMed ID: 22157657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.